Clinical advances in proton spatially fractionated radiation therapy
Abstract Spatially fractionated radiation therapy (SFRT) intentionally creates a heterogeneous dose distribution within a tumor, with alternating high-dose peaks and low-dose valleys. This approach offers a different route to dose escalation for bulky, locally advanced tumors and lesions near organs at risk. Proton SFRT (pSFRT) combines this spatial heterogeneity with the finite range of protons, rapid distal dose fall-off, and pencil beam scanning. It may therefore reduce dose outside the target while preserving intratumoral peak-valley patterns. Current pSFRT platforms include proton GRID, proton LATTICE, and proton minibeam radiation therapy, but their clinical maturity differs markedly. Available studies support the technical feasibility and short-term tolerability of pSFRT and suggest potential benefits in tumor control and symptom relief across several cancer types. However, the evidence base is limited by cohort sizes, substantial disease heterogeneity, variability in treatment approaches, frequent use of subsequent radiation therapy or systemic therapy, and relatively short follow-up periods. No included comparative clinical study demonstrated an advantage over photon SFRT or conventional proton therapy. Additional barriers include range and motion uncertainty, inconsistent characterization of peak and valley doses, patient-specific quality assurance, limited radiobiological modeling, and uncertain patient selection. This review examines the evolution of SFRT, the physical rationale for proton delivery, the main pSFRT techniques, published human evidence, and current translational challenges. It also outlines priorities for dose-reporting standards, multicenter prospective studies, and rational integration with systemic therapies, and highlights major unresolved questions that must be addressed before broader clinical application.
Authors
- Linhan Ye (ORCID: https://orcid.org/0000-0001-8180-3152)
- Shuming Shi
- Jiaran Li
- Yang Zhang
- Shiwen Hou
- Shuanghu Yuan (ORCID: https://orcid.org/0009-0000-0156-2783)
Institutions
- University of Science and Technology of China (CN)
Publication Details
- Journal
- Clinical Cancer Bulletin
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1007/s44272-026-00079-x
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- University of Science and Technology of China